12,000,000 Shares of Common Stock and Pre-Funded Warrants to Purchase 5,800,000 Shares of Common Stock TELA Bio, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • October 23rd, 2024 • TELA Bio, Inc. • Surgical & medical instruments & apparatus • New York
Introductory. TELA Bio, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the underwriters named in Schedule A (the “Underwriters”) (i) an aggregate of 12,000,000 shares of its common stock, par value $0.001 per share (the “Shares”), and (ii) pre-funded warrants of the Company, in the form attached hereto as Schedule B (the “Pre-Funded Warrants”), to purchase 5,800,000 Shares (the “Warrant Shares”). The 12,000,000 Shares to be sold by the Company are called the “Firm Shares.” In addition, the Company has granted to the Underwriters an option to purchase up to an additional 2,670,000 Shares as provided in Section 2. The additional 2,670,000 Shares to be sold by the Company pursuant to such option are collectively called the “Optional Shares.” The Firm Shares and, if and to the extent such option is exercised, the Optional Shares are collectively called the “Offered Shares.” The Offered Shares and the Pre-Funded Warrants are collectively referred to herein as t
